Flu, RSV, and COVID-19 vaccine recommendations: Fall and winter 2023–2024
Dec. 2023Important Notices
Flu, RSV, and COVID-19 vaccines are recommended by the Centers for Disease Control and Prevention (CDC) to reduce the risk of serious illness, hospitalizations, long-term health impacts, and death.
The CDC recommends an annual influenza vaccination for everyone 6 months old and older in the United States.
The agency also recommends an updated COVID-19 vaccine for the 2023–2024 respiratory viral season. Updated vaccines include Pfizer-BioNTech, Moderna, and Novavax COVID-19 vaccines. Everyone 5 years old and older should get one dose of an updated COVID-19 vaccine to be up to date and protected against serious illness from COVID-19. Children 6 months to 4 years old need multiple doses of a COVID-19 vaccine to be up to date, including at least one dose of the updated vaccine. People who are moderately or severely immunocompromised may get additional doses of an updated COVID-19 vaccine.
Single-dose RSV vaccines—Abrysvo and Arexvy—are available for adults 60 years old and older using shared clinical decision making. Additionally, Abrysvo is recommended for individuals who are 32 to 36 weeks pregnant, using seasonal administration, to prevent RSV lower respiratory tract infection in infants.
Specific to pediatrics, children younger than 8 months old who were born during or are entering their first RSV season are recommended to receive one dose of Beyfortus (nirsevimab) (50 mg for infants <5 kg and 100 mg for infants ≥5 kg). Children 8 months to 19 months old who are at increased risk of severe RSV disease and are entering their second season are recommended to receive one 200 mg dose of Beyfortus (nirsevimab).
Visit the CDC website for more information about the flu, RSV, and COVID-19 vaccines:
UPMC Health Plan updates the benefit status of vaccines as information is published by clinical and regulatory groups, such as ACIP, CDC, CMS, USPSTF, and AAP, and will follow all published requirements in a timely manner. Member cost share may be applied in certain circumstances, such as use of an out-of-network provider or use that does not follow ACIP recommendations. Patients should refer to the UPMC Health Plan member website for a full list of participating pharmacies and/or contact Member Services for assistance in determining coverage for various vaccines.
The provider of care is ultimately responsible for providing accurate and compliant information on all submission of claims and/or billing information.
The CDC recommends an annual influenza vaccination for everyone 6 months old and older in the United States.
The agency also recommends an updated COVID-19 vaccine for the 2023–2024 respiratory viral season. Updated vaccines include Pfizer-BioNTech, Moderna, and Novavax COVID-19 vaccines. Everyone 5 years old and older should get one dose of an updated COVID-19 vaccine to be up to date and protected against serious illness from COVID-19. Children 6 months to 4 years old need multiple doses of a COVID-19 vaccine to be up to date, including at least one dose of the updated vaccine. People who are moderately or severely immunocompromised may get additional doses of an updated COVID-19 vaccine.
Single-dose RSV vaccines—Abrysvo and Arexvy—are available for adults 60 years old and older using shared clinical decision making. Additionally, Abrysvo is recommended for individuals who are 32 to 36 weeks pregnant, using seasonal administration, to prevent RSV lower respiratory tract infection in infants.
Specific to pediatrics, children younger than 8 months old who were born during or are entering their first RSV season are recommended to receive one dose of Beyfortus (nirsevimab) (50 mg for infants <5 kg and 100 mg for infants ≥5 kg). Children 8 months to 19 months old who are at increased risk of severe RSV disease and are entering their second season are recommended to receive one 200 mg dose of Beyfortus (nirsevimab).
Visit the CDC website for more information about the flu, RSV, and COVID-19 vaccines:
- Immunization Overview for Fall and Winter 2023-2024 | CDC
- Stay Up to Date with COVID-19 Vaccines
- Updated COVID-19 Vaccine Recommendations
- 2023-2024 CDC Flu Vaccination Recommendations
- Use of Respiratory Syncytial Virus Vaccines in Older Adults
UPMC Health Plan updates the benefit status of vaccines as information is published by clinical and regulatory groups, such as ACIP, CDC, CMS, USPSTF, and AAP, and will follow all published requirements in a timely manner. Member cost share may be applied in certain circumstances, such as use of an out-of-network provider or use that does not follow ACIP recommendations. Patients should refer to the UPMC Health Plan member website for a full list of participating pharmacies and/or contact Member Services for assistance in determining coverage for various vaccines.
The provider of care is ultimately responsible for providing accurate and compliant information on all submission of claims and/or billing information.
Recent Announcements
Important announcement – Telehealth submissions
As of October 1, 2025, UPMC Health Plan continues to accept the submission of telehealth claims. Providers may conduct telehealth visits for UPMC Health Plan members in all UPMC Insurance products. UPMC Insurance products include UPMC Advantage group and individual products, UPMC for Life Medicare Advantage plans, UPMC for Kids CHIP plans, UPMC Community HealthChoices, and UPMC for You Medical Assistance plans.Sep. 2025Important Notices
October 2025 UPMC for You and UPMC Community HealthChoices Formulary Update
Effective October 1st, 2025, Xifaxan and Retin-A (cream, gel) will no longer be covered by UPMC for You and UPMC Community HealthChoices due to non-participation in the Medicaid Drug Rebate Program.Sep. 2025Pharmacy Updates
Biosimilar Medication Formulary Updates
Updates to formulary biosimilar medications for denosumab, eculizumab, and ustekinumab productsSep. 2025Pharmacy Updates